Neutropenia During Therapy With Peginterferon and Ribavirin in HIV-Infected Subjects With Chronic Hepatitis C and the Risk of Infections | Zendy

Sergio SerranoVillar | Zendy; Carmen Quereda | Zendy; Ana Moreno | Zendy; María Jesús PérezElías | Zendy; José L. Casado | Zendy; Ana Royuela | Zendy; Fernando Dronda | Zendy; Enrique Navas | Zendy; José Manuel Hermida | Zendy; Santiago Moreno | Zendy

Open Access

Neutropenia During Therapy With Peginterferon and Ribavirin in HIV-Infected Subjects With Chronic Hepatitis C and the Risk of Infections

Author(s) -

Sergio SerranoVillar,

Carmen Quereda,

Ana Moreno,

María Jesús PérezElías,

José L. Casado,

Ana Royuela,

Fernando Dronda,

Enrique Navas,

José Manuel Hermida,

Santiago Moreno

Publication year - 2013

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cit221

Subject(s) - medicine , neutropenia , ribavirin , hepatitis c virus , prospective cohort study , immunology , hepatitis c , gastroenterology , leukopenia , chemotherapy , virus

It is unclear whether pegylated interferon (peg-IFN) -induced neutropenia in subjects coinfected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) is associated with increased risk of serious infections.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research